Phospholamban Cardiomyopathy Leading to Advanced Heart Failure in an Active Duty Service Member

Ryan Choi1, Robert N Geis2, Satoshi Shin2

  • 1Department of Internal Medicine, Naval Medical Center San Diego, San Diego, CA 92134, USA.

Military Medicine
|August 23, 2024
PubMed

Insights

A rare phospholamban mutation caused severe heart failure in a young service member with familial dilated cardiomyopathy (DCM). Genetic screening is crucial for DCM families, highlighting a gap in military medical standards.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Dilated cardiomyopathy (DCM) is a severe heart condition.
  • Genetic mutations, such as in phospholamban, are rare causes of DCM.
  • Familial DCM can present in young individuals.

Purpose of the Study:

  • To report a case of a young service member with familial DCM.
  • To emphasize the role of phospholamban mutations in DCM.
  • To highlight the need for genetic screening and updated military medical standards.

Main Methods:

  • Case report of a young service member.
  • Clinical presentation and diagnostic workup for advanced heart failure.
  • Identification of an autosomal dominant phospholamban mutation.

Main Results:

  • The patient presented with advanced heart failure due to familial DCM.
  • An autosomal dominant phospholamban mutation was identified as the cause.
  • Successful heart transplantation was performed 23 days after presentation.

Conclusions:

  • Phospholamban mutations are a significant, albeit rare, cause of DCM.
  • Genetic screening and surveillance are vital for families with a history of DCM.
  • Current military accession medical standards may need revision to include genetic screening for conditions like DCM.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
160
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
545
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K